217 related articles for article (PubMed ID: 7846259)
1. Personality disorder comorbidity with major depression and response to fluoxetine treatment.
Fava M; Bouffides E; Pava JA; McCarthy MK; Steingard RJ; Rosenbaum JF
Psychother Psychosom; 1994; 62(3-4):160-7. PubMed ID: 7846259
[TBL] [Abstract][Full Text] [Related]
2. Personality disorders and depression.
Fava M; Farabaugh AH; Sickinger AH; Wright E; Alpert JE; Sonawalla S; Nierenberg AA; Worthington JJ
Psychol Med; 2002 Aug; 32(6):1049-57. PubMed ID: 12214786
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
4. Problem-solving ability and comorbid personality disorders in depressed outpatients.
Harley R; Petersen T; Scalia M; Papakostas GI; Farabaugh A; Fava M
Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
[TBL] [Abstract][Full Text] [Related]
5. The relationship of personality disorders to treatment outcome in depressed outpatients.
Mulder RT; Joyce PR; Luty SE
J Clin Psychiatry; 2003 Mar; 64(3):259-64. PubMed ID: 12716266
[TBL] [Abstract][Full Text] [Related]
6. Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment.
Fava M; Rosenbaum JF; Pava JA; McCarthy MK; Steingard RJ; Bouffides E
Am J Psychiatry; 1993 Aug; 150(8):1158-63. PubMed ID: 7848377
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
Farabaugh A; Mischoulon D; Schwartz F; Pender M; Fava M; Alpert J
Depress Anxiety; 2007; 24(6):433-9. PubMed ID: 17086540
[TBL] [Abstract][Full Text] [Related]
8. Residual symptoms in depressed patients who respond acutely to fluoxetine.
Nierenberg AA; Keefe BR; Leslie VC; Alpert JE; Pava JA; Worthington JJ; Rosenbaum JF; Fava M
J Clin Psychiatry; 1999 Apr; 60(4):221-5. PubMed ID: 10221281
[TBL] [Abstract][Full Text] [Related]
9. The impact of medical comorbidity on acute treatment in major depressive disorder.
Iosifescu DV; Nierenberg AA; Alpert JE; Smith M; Bitran S; Dording C; Fava M
Am J Psychiatry; 2003 Dec; 160(12):2122-7. PubMed ID: 14638581
[TBL] [Abstract][Full Text] [Related]
10. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
12. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
[TBL] [Abstract][Full Text] [Related]
13. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.
Cassano P; Soares CN; Cohen LS; Lyster AK; Fava M
Arch Womens Ment Health; 2004 Jul; 7(3):167-71. PubMed ID: 15241662
[TBL] [Abstract][Full Text] [Related]
14. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
[TBL] [Abstract][Full Text] [Related]
15. Eating disorder symptomatology in major depression.
Fava M; Abraham M; Clancy-Colecchi K; Pava JA; Matthews J; Rosenbaum JF
J Nerv Ment Dis; 1997 Mar; 185(3):140-4. PubMed ID: 9091594
[TBL] [Abstract][Full Text] [Related]
16. Hypochondriacal concerns in depressed outpatients.
Demopulos C; Fava M; McLean NE; Alpert JE; Nierenberg AA; Rosenbaum JF
Psychosom Med; 1996; 58(4):314-20. PubMed ID: 8827793
[TBL] [Abstract][Full Text] [Related]
17. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
Ongur D; Farabaugh A; Iosifescu DV; Perlis R; Fava M
Psychother Psychosom; 2005; 74(3):173-8. PubMed ID: 15832068
[TBL] [Abstract][Full Text] [Related]
18. Relationships between major depressive disorder and comorbid anxiety and personality disorders.
Farabaugh A; Fava M; Mischoulon D; Sklarsky K; Petersen T; Alpert J
Compr Psychiatry; 2005; 46(4):266-71. PubMed ID: 16175757
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine and desipramine in major depressive disorder.
Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
[TBL] [Abstract][Full Text] [Related]
20. Predicting response to fluoxetine in geriatric patients with major depression.
Koran LM; Hamilton SH; Hertzman M; Meyers BS; Halaris AE; Tollefson GD; Downs JM; Folks DG; Jeste DV; Lazarus LW
J Clin Psychopharmacol; 1995 Dec; 15(6):421-7. PubMed ID: 8748431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
